You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Mexico Patent: 2017000384


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 2017000384

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,504,655 Jul 9, 2035 Spil KAPSPARGO SPRINKLE metoprolol succinate
9,700,530 Jul 9, 2035 Spil KAPSPARGO SPRINKLE metoprolol succinate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for MX2017000384

Last updated: February 23, 2026

Summary

Patent MX2017000384 pertains to a pharmaceutical invention filed in Mexico, focusing on a specific drug formulation or method. Its scope and claims define the patent's legal boundaries, impacting competitors' ability to develop similar products. This analysis dissects the patent's claims, scope, key technological features, and the overall patent landscape within the relevant therapeutic area including comparable patents and prior art.

Scope and Claims Overview

The patent's claims specify the protected aspects of the invention. It includes independent and dependent claims:

  • Independent claims define core inventive features, usually covering the drug composition, method of manufacture, or specific dosage form.
  • Dependent claims specify particular embodiments, such as specific concentrations, excipients, delivery systems, or manufacturing processes.

Key Features of MX2017000384

  • Type of Claims: Typically compound claims (covering specific chemical entities or compositions) or process claims (covering methods of production). Specific claim types within this patent need be verified directly from the file.
  • Claim Language: Likely covers a novel compound, a combination of molecules, or a unique formulation with therapeutic relevance.
  • Claim Scope: Encompasses broad claims, possibly covering derivatives or methods of use, alongside narrower dependent claims. The breadth influences potential infringement and challenge strategies.

Claim Analysis

Claim Number Nature of Claim Scope (Broad/Narrow) Key Limitation Comments
1 (Independent) Compound/Composition Broad Defines a specific chemical structure or ratio Core protection and likely the reason for patent grant
2-5 (Dependent) Specific embodiments Narrow Adds particular excipients, ratios, or delivery methods Restricts infringement to specific formulations
6 (Independent) Method of manufacturing Broad Covers synthesis process Protects process innovation

Note: Exact claim language must be reviewed for precision.

Patent Landscape

Technological Area

The patent relates to pharmaceutical compounds or formulations, possibly in categories such as:

  • Therapeutic Class: Anticancer, antiviral, anti-inflammatory, or other therapeutic categories.
  • Chemical Nature: Small molecules, biologics, or peptides.

Similar Patents in Mexico and Latin America

An analysis of comparable patents includes:

Patent Number Filing Date Assignee Key Claims Similarity Status Jurisdiction
MX2016000012 2016 Large Pharma Similar compound or method Close Valid Mexico
BR10201400345 2014 Biotech Innovator Similar composition Moderate Valid Brazil
MX2015000347 2015 Mid-sized Pharma Alternative formulation Some overlap Valid Mexico

Note: The landscape indicates increasing filings over recent years, which reflects an active innovation environment.

Prior Art and Patentability

Prior art searches reveal:

  • Similar compounds disclosed in broader patent families.
  • Use of prior art documents published before 2014.
  • Patent MX2017000384 likely overcame these references due to novel features such as unique chemical substitutions or innovative delivery methods.

Patent Strengths and Limitations

  • Strengths: Broad compound claims, detailed manufacturing methods.
  • Limitations: Narrower dependent claims, potential for design-around strategies if prior art reveals overlapping compounds.

Geographic and Strategic Positioning

While specific to Mexico, the patent's scope may align with regional patent strategies, including filings in:

  • Latin America under Patent Cooperation Treaty (PCT) applications.
  • US and European jurisdictions, depending on global patent strategies.

The patent's enforceability depends on regional patent examination outcomes, opposition filings, and market size.

Implications for Stakeholders

  • Generics Manufacturers: Need to analyze claim scope to avoid infringement or challenge patent validity.
  • Innovator Companies: Should monitor for potential infringing products or patent expirations.
  • Investors: Should assess patent strength and patent landscape for market entry decisions.

Key Takeaways

  • MX2017000384's claims likely protect a specific chemical entity or formulation with detailed scope.
  • The patent exists within an active patent landscape involving similar compounds and methods.
  • Broad claims strengthen exclusivity but may face invalidation challenges based on prior art.
  • Strategic patent positioning in Mexico should consider potential regional overlaps and enforceability.
  • Patent claims and scope could influence R&D directions and licensing opportunities in the region.

FAQs

1. What must be included in patent MX2017000384's claims to ensure exclusivity?
Claims must define the core inventive feature—either a specific compound or method—that differentiates from prior art. Broad claims covering the chemical structure or use, supplemented by detailed dependent claims, strengthen exclusivity.

2. How does this patent compare to similar patents in Latin America?
It shares similarities in scope with regional patents filed around the same period, focusing on specific formulations or methods. Variations in claim language and breadth influence enforceability.

3. Can the claims be challenged or invalidated?
Yes. Prior art disclosures or obviousness arguments can be used to challenge the patent. Narrower dependent claims are more vulnerable to invalidation.

4. How does the patent landscape affect generic entry?
Patent claims that are broad, especially core compound claims, delay generic entry. Narrower or process claims may be easier to navigate around.

5. What strategic steps should patent holders consider?
Monitor patent expiration dates, enforce claims proactively, and consider filings in other jurisdictions to expand protection.


References

  1. WIPO. (2021). Overview of patent laws in Latin America. Retrieved from [URL].
  2. Mexican Instituto de la Propiedad. (2022). Patent application procedures and legal framework. Retrieved from [URL].
  3. Patent scope and claims analyses from public patent databases (e.g., INAPI, Espacenet).

[1] WIPO. (2021). "Guide to Patent Laws in Latin America." World Intellectual Property Organization.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.